fluoxetine has been researched along with Pancreatic Neoplasms in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of mirtazapine and fluoxetine, representatives of the noradrenergic and specific serotonergic antidepressant (NaSSA) and selective serotonin reuptake inhibitor (SSRI) antidepressant respectively, on body weight, ingestive behavior, locomotor activity and tumor growth of human pancreatic carcinoma xenografts in nude mice." | 3.74 | Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice. ( Jia, L; Li, YY; Shang, YY, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saponara, E | 1 |
| Visentin, M | 1 |
| Baschieri, F | 1 |
| Seleznik, G | 1 |
| Martinelli, P | 1 |
| Esposito, I | 1 |
| Buschmann, J | 1 |
| Chen, R | 1 |
| Parrotta, R | 1 |
| Borgeaud, N | 1 |
| Bombardo, M | 1 |
| Malagola, E | 1 |
| Caflisch, A | 1 |
| Farhan, H | 1 |
| Graf, R | 1 |
| Sonda, S | 1 |
| Alidjinou, EK | 1 |
| Bertin, A | 1 |
| Sane, F | 1 |
| Caloone, D | 1 |
| Engelmann, I | 1 |
| Hober, D | 1 |
| Jia, L | 1 |
| Shang, YY | 1 |
| Li, YY | 1 |
3 other studies available for fluoxetine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Transdifferentiati | 2018 |
Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.
Topics: Antiviral Agents; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Coxsackievirus Infect | 2019 |
Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.
Topics: Antiviral Agents; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Coxsackievirus Infect | 2019 |
Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.
Topics: Antiviral Agents; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Coxsackievirus Infect | 2019 |
Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.
Topics: Antiviral Agents; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Coxsackievirus Infect | 2019 |
Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Ca | 2008 |